289 related articles for article (PubMed ID: 26551483)
1. Safety and effectiveness of insulin detemir in combination with oral antidiabetic agents in an outpatient specialist setting: results of the Italian SOLVE™ observational study.
Caputo S; Maran A; Mannino D; Morano S; Lastoria G; Nicoziani P
Minerva Endocrinol; 2015 Dec; 40(4):249-58. PubMed ID: 26551483
[TBL] [Abstract][Full Text] [Related]
2. Weight-neutral effect of once-daily insulin detemir in Chinese type 2 diabetes patients: subgroup analysis of the SOLVE study.
Pan C; Han P; Ji L; Ji Q; Lu J; Lin J; Liu J; Su B; Shi J; Wang P
J Diabetes; 2015 Mar; 7(2):222-30. PubMed ID: 24909984
[TBL] [Abstract][Full Text] [Related]
3. Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study.
Meneghini LF; Dornhorst A; Sreenan S;
Curr Med Res Opin; 2009 Apr; 25(4):1029-35. PubMed ID: 19281426
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness and safety of initiation of once-daily insulin detemir in Chinese patients with type 2 diabetes previously treated with different quantities of oral anti-diabetic drugs: subgroup analysis of the Chinese SOLVE™ Study].
Pan C; Ji L; Lu J; Yang W; Zhou Z;
Zhonghua Nei Ke Za Zhi; 2015 Jul; 54(7):612-7. PubMed ID: 26359024
[TBL] [Abstract][Full Text] [Related]
5. Insulin Detemir in Combination with Oral Antidiabetic Drugs Improves Glycemic Control in Persons with Type 2 Diabetes in Near East Countries: Results from the Lebanese Subgroup.
Echtay A; Andari E; Atallah P; Moufarrege R; Nemr R
Ethn Dis; 2017 Jan; 27(1):45-54. PubMed ID: 28115821
[TBL] [Abstract][Full Text] [Related]
6. Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study.
Dornhorst A; Lüddeke HJ; Sreenan S; Kozlovski P; Hansen JB; Looij BJ; Meneghini L;
Int J Clin Pract; 2008 Apr; 62(4):659-65. PubMed ID: 18324957
[TBL] [Abstract][Full Text] [Related]
7. [Once daily insulin detemir in patients with type 2 diabetes: results of German centers in a 6-month international observational study (SOLVE)].
Liebl A; Wilhelm B; Kaiser M
MMW Fortschr Med; 2012 Dec; 154 Suppl 4():102-9. PubMed ID: 23326928
[TBL] [Abstract][Full Text] [Related]
8. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
[TBL] [Abstract][Full Text] [Related]
9. [RESOLUTE Study in the Czech Republic: insulin glargine improves the compensation of type 2 diabetes in patients with unsatisfactory results of therapy with a combination of insulin detemir and oral antidiabetics. Results of the nonintervention RESOLUTE Project in the Czech Republic].
Kvapil M
Vnitr Lek; 2013 Sep; 59(9):800-6. PubMed ID: 24073952
[TBL] [Abstract][Full Text] [Related]
10. [The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study].
Pan CY; Ji LN; Lu JM; Yang WY; Zhou ZG; Zou DJ; Ji QH; Han P; Liu J; Li Q; Su BL; Li YB; Gao ZN; Wang PH; Yin SN; Dong YH; Yang T; Sun K; Li H; Hong X; Lin J; Shi JM; Yang XJ; Fang H; Yan XD;
Zhonghua Nei Ke Za Zhi; 2013 Jan; 52(1):11-5. PubMed ID: 23710808
[TBL] [Abstract][Full Text] [Related]
11. Improvement of glycemic control with addition of insulin detemir to existing antidiabetic therapy: a sub-group analysis of A1chieve observational study.
Kesavadev J; Joshi SR
J Assoc Physicians India; 2013 Jan; 61(1 Suppl):28-30. PubMed ID: 24482985
[TBL] [Abstract][Full Text] [Related]
12. Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors.
Zhang T; Ji L; Gao Y; Zhang P; Zhu D; Li X; Ji J; Zhao F; Zhang H; Guo X
Diabetes Technol Ther; 2017 Nov; 19(11):675-684. PubMed ID: 29090977
[TBL] [Abstract][Full Text] [Related]
13. Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice.
Ross S; Dzida G; Ji Q; Kaiser M; Ligthelm R; Meneghini L; Nazeri A; Orozco-Beltran D; Pan C; Svendsen AL;
J Diabetes; 2014 May; 6(3):243-50. PubMed ID: 24103141
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
[TBL] [Abstract][Full Text] [Related]
15. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes.
Marre M; Pinget M; Gin H; Thivolet C; Hanaire H; Robert JJ; Fontaine P
Diabetes Metab; 2009 Dec; 35(6):469-75. PubMed ID: 19914118
[TBL] [Abstract][Full Text] [Related]
16. Improved glycemic control with weight loss and a low risk of hypoglycemia with insulin detemir: insights from the Italian cohort of the PREDICTIVE study after 6-month observation in type 2 diabetic subjects.
Perriello G; Caputo S; De Pergola G; Di Carlo A; Grassi G; Lapolla A; Pata P; Solerte SB; Zaccardi F
Expert Opin Pharmacother; 2011 Nov; 12(16):2449-55. PubMed ID: 21988213
[TBL] [Abstract][Full Text] [Related]
17. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
Meneghini L; Koenen C; Weng W; Selam JL
Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial.
Zhang T; Lin M; Li W; Fan X; Du T; Zhao Y; Zhang X
Adv Ther; 2016 Feb; 33(2):178-85. PubMed ID: 26809253
[TBL] [Abstract][Full Text] [Related]
19. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
[TBL] [Abstract][Full Text] [Related]
20. [Prospective observational study of insulin detemir in patients with poorly controlled type 2 diabetes mellitus initiating insulin therapy for the first time (SOLVE Study)].
Orozco-Beltrán D; Artola-Menéndez S
Aten Primaria; 2016 Feb; 48(2):95-101. PubMed ID: 26054893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]